What Is Tesamorelin? The Only FDA-Approved GHRH Peptide Explained
Tesamorelin (Egrifta) is the only FDA-approved GHRH peptide, approved in 2010 for HIV-associated lipodystrophy. This guide covers its mechanism, FDA approval history, visceral fat biology, comparison with CJC-1295 and Ipamorelin, monitoring requirements, and access in Thailand.